January 10, 2023

Tuesday, January 10, 2023

by Gist Healthcare

https://assets.pippa.io/shows/622b8f5080a3a00013890f23/show-cover.png

Listen Time: 7:39

Gist Healthcare joins healthcare management consultancy group Kaufman Hall. Biogen’s latest Alzheimer’s drug lecanemab was granted accelerated approval by the FDA. And, the FTC has proposed a ban on non-compete agreements, which could impact how the healthcare industry operates. That’s coming up on today’s episode of Gist Healthcare Daily.


Hosted on Acast. See acast.com/privacy for more information.